Table 2.
Characteristics | TCGA cohort (N = 372) | GEO cohort (N = 165) | |||||
---|---|---|---|---|---|---|---|
High risk | Low risk | p-value | High risk | Low risk | p-value | ||
Age (years) | 0.205 | 0.033 | |||||
<60 | 34 | 45 | 15 | 27 | |||
≥60 | 152 | 141 | 68 | 55 | |||
Gender | 0.075 | 0.84 | |||||
Male | 130 | 146 | 67 | 68 | |||
Female | 56 | 40 | 16 | 14 | |||
T stage | <0.001 | 0.002 | |||||
T0–2 | 42 | 79 | 53 | 58 | |||
T3–4 | 143 | 107 | 23 | 7 | |||
Tx | 1 | 0 | 7 | 17 | |||
Lymph node metastasis | <0.001 | 0.243 | |||||
Yes | 76 | 48 | 10 | 5 | |||
No | 104 | 117 | 72 | 77 | |||
Unknown | 6 | 21 | 1 | 0 | |||
Metastasis | 0.775 | 0.443 | |||||
Yes | 5 | 3 | 5 | 2 | |||
No | 91 | 92 | 78 | 80 | |||
Unknown | 90 | 91 | 0 | 0 | |||
Diagnosis subtype | 0.075 | ||||||
Papillary | 49 | 68 | NA | NA | |||
Non-papillary | 135 | 115 | NA | NA | |||
Unknown | 2 | 3 | NA | NA | |||
Histologic grade | 0.108 | 0.015 | |||||
High | 180 | 171 | 38 | 22 | |||
Low | 5 | 14 | 45 | 60 | |||
Unknown | 1 | 1 |
NA, Not Applicable.